GVM to launch its first China facility in early 2017

Days after opening a €3m diagnostics centre in Moscow, Italian hospital operator Gruppo Villa Maria (GVM) says its first facility in China is to launch early next year. We speak to vice-president Bruno Biagi about the group’s international strategy.

Singapore-based Fullerton to IPO

Singapore-based healthcare provider Fullerton has received approval to list on the Singapore stock exchange, but could its S$1.5bn (almost €1bn) valuation be too high?

Unilabs set to sell for €1.5bn within weeks

Sources close to the Western European diagnostics chain say JP Morgan and Goldman Sachs are in the process of raising the money to allow Synlabs to buy Unilabs in a deal valued at €1.5bn. And what about French reference lab Cerba, which PAI plans to sell before Christmas?

Sistema may buy new hospital near Moscow

Russian conglomerate Sistema is one of two investors competing to buy up to 51% of a new hospital in the Moscow region for an estimated €11m, according to local reports.

NHS trusts still reluctant to outsource tests

NHS trusts in the UK are still avoiding outsourcing tests to private labs, despite the private sector demonstrating greater efficiency, says a consultant who has been working closely with both.